Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Celltrion (068270) – Decision on Bonus Issue / 2026-05-21 Disclosures
  • [Disclosure] SK Hynix (000660 / SKHY) – Decision on Disposal of Treasury Shares / 2025-01-23 Semiconductors
  • [Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2025-07-03 Semiconductors
  • [Disclosure] PSK Holdings (031980) – Value-up Plan (Voluntary Filing) / 2026-03-30 Semiconductors
  • [Disclosure] Samsung Biologics (207940) – Results of Annual General Meeting of Shareholders / 2026-03-20 Disclosures
  • [Disclosure] KEPCO (015760 / KEP) – (Correction) Decision to Guarantee Debt for Others / 2025-08-12 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Decision on Corporate Split (Correction) / 2024-07-12 Disclosures
  • [Disclosure] LEENO Industrial (058470) – Modification Listing (Change in Par Value) (Stock Split) / 2025-04-24 Disclosures

[Disclosure] SK Hynix (000660 / SKHY) – Decision on Listing Shares, etc. on Foreign Securities Market / 2026-06-24

Posted on June 24, 2026August 11, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART
Market: KOSPI (000660)

💡 3-Second Summary

SK Hynix has decided to list American Depositary Receipts (ADRs) on the U.S. Nasdaq Global Select Market by issuing 177,900,000 ADRs based on 17,790,000 new common shares to expand its global investor base.

📊 [Key Summary & Financial Figures]

  • Company Name: SK Hynix Inc.
  • Type & Quantity of Shares to be Listed: Registered Common Shares 17,790,000 shares (Maximum new share offering limit)
  • Total Number of Issued Shares: Common Shares 712,702,365 shares
  • Public Offering Method: New Share Issuance (17,790,000 shares)
  • Purpose of Financing: Facility Capital (Yongin Semiconductor Cluster Phase 1 Fab construction, Cheongju P&T7 Advanced Packaging Fab construction/equipment/incidental expenses, EUV Scanner machinery acquisition and facility investment)
  • Securities to be Listed & Quantity: DR Listing 177,900,000 shares (Based on 1 : 10 underlying share to ADR ratio)
  • Stock Exchange & Country: U.S. Nasdaq Global Select Market (United States)
  • Purpose of Overseas Listing: Expansion of global investor base
  • Expected Listing Date: July 10, 2026 (Subject to change based on demand forecasting)
  • Board Resolution Date: June 24, 2026 (6 outside directors present, 0 absent)
  • Other Key Decision Details:
    • Definitive disclosure regarding prior inquiry disclosure requests concerning U.S. listing reports.
    • All new shares serve as underlying shares for ADRs allocated to overseas investors; no domestic offering or sale will occur.
    • Underlying shares will be deposited with Korea Securities Depository acting as custodian for overseas depositary Citibank, N.A.
    • Listed share counts and ADR ratio (1:10) are maximum reference limits; final terms will be determined via bookbuilding results and submitted through amended disclosures.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verifying Overseas Demand Forecasting Results and Finalized Listing Terms

This disclosure announces the definitive board decision to list ADRs on the U.S. Nasdaq market based on new share issuance. Since the reported share and ADR quantities represent maximum reference limits, tracking the finalized issue size, offering price, underlying share to ADR ratio, and exact listing schedule determined through overseas institutional bookbuilding is important to understand the transaction structure and total capital raised. Relevant final details can be verified in future correction disclosures, major event disclosures (Capital Increase Decision), subsequent periodic reports (Quarterly, Half-Year, or Annual Reports), and registration statements.

📢 Disclaimer and Source Notice

Source: This content was structured and generated based on official submission data from the Financial Supervisory Service’s DART system.

Investment Risk Notice: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] Hanwha Systems (272210) – Decision on Acquisition of Tangible Assets / 2026-06-24
Next Post: [Disclosure] Hana Micron (067310) – Additional Listing (Exercise of Stock Options) / 2026-06-24

Related Posts

  • [Disclosure] Hyundai Motor (005380) – Results of Annual General Meeting of Shareholders / 2025-03-20 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Clarification on Rumors or News Reports / 2025-08-27 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Pre-announcement of Financial Results / 2025-07-15 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Decision on Record Date for Cash and Property Dividend / 2025-07-24 Disclosures
  • [Disclosure] PSK Holdings (031980) – Decision on Cash and In-Kind Dividend / 2025-02-11 Semiconductors
  • [Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P51 (Keytruda Biosimilar) in Korea / 2025-01-15 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Earnings Release Announcement (Informational Disclosure) / 2026-07-13 Disclosures
  • [Disclosure] Celltrion (068270) – Additional Listing (Exercise of Stock Options) / 2026-05-15 Disclosures
  • [Disclosure] ALTEOGEN (196170) – Decision on Merger / 2024-11-07 Disclosures
  • [Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Holding / 2024-05-10 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – Acquisition of Shares in Other Corporation / 2024-09-11 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Acquisition of Shares in Other Corporation / 2025-02-10 Disclosures
  • [Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan in Korea for CT-P44 (Darzalex Biosimilar) / 2025-07-03 Disclosures
  • [Disclosure] SK hynix (000660 / SKHY) – Investor Relations (IR) Holding (Information Disclosure) / 2025-10-15 Semiconductors

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme